Scott Power
Stock Analyst at Morgans
(0.27)
# 4,630
Out of 5,124 analysts
239
Total ratings
34.6%
Success rate
-5.9%
Average return
Main Sectors:
Stocks Rated by Scott Power
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: AYA Artrya Limited | Reiterated: Buy | $4.25 | $3.66 | +16.12% | 1 | Oct 26, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Reiterated: Buy | $3.19 | $2.87 | +11.15% | 10 | Oct 21, 2026 | |
| NZE: EBO EBOS Group Limited | Reiterated: Buy | $28.28 | $21.70 | +30.30% | 24 | Oct 21, 2026 | |
| ASX: BB1 BlinkLab Limited | Reiterated: Buy | $1.76 | $0.57 | +208.77% | 3 | Oct 1, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Reiterated: Buy | $2.90 | $1.28 | +126.56% | 16 | Oct 1, 2026 | |
| ASX: CGS Cogstate Limited | Reiterated: Buy | $4.07 | $3.60 | +13.06% | 1 | Sep 28, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $0.79 | $0.51 | +54.90% | 10 | Sep 10, 2026 | |
| ASX: IPD ImpediMed Limited | Downgraded: Hold | n/a | $0.004 | - | 33 | Aug 31, 2026 | |
| ASX: MX1 Micro-X Limited | Downgraded: Hold | $0.08 → $0.06 | $0.03 | +100.00% | 43 | Aug 31, 2026 | |
| ASX: PNV PolyNovo Limited | Reiterated: Buy | $1.48 → $1.21 | $0.89 | +36.72% | 13 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.59 | $6.25 | +37.44% | 10 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.85 → $0.05 | $0.05 | n/a | 8 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.32 | $2.85 | n/a | 18 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.55 | $0.26 | n/a | 18 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.09 → $1.20 | $0.75 | n/a | 19 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.33 → $1.89 | $5.05 | n/a | 12 | Dec 14, 2021 |
Artrya Limited
Oct 26, 2026
Reiterated: Buy
Price Target: $4.25
Current: $3.66
Upside: +16.12%
Sigma Healthcare Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $3.19
Current: $2.87
Upside: +11.15%
EBOS Group Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $28.28
Current: $21.70
Upside: +30.30%
BlinkLab Limited
Oct 1, 2026
Reiterated: Buy
Price Target: $1.76
Current: $0.57
Upside: +208.77%
Imricor Medical Systems, Inc.
Oct 1, 2026
Reiterated: Buy
Price Target: $2.90
Current: $1.28
Upside: +126.56%
Cogstate Limited
Sep 28, 2026
Reiterated: Buy
Price Target: $4.07
Current: $3.60
Upside: +13.06%
Aroa Biosurgery Limited
Sep 10, 2026
Reiterated: Buy
Price Target: $0.79
Current: $0.51
Upside: +54.90%
ImpediMed Limited
Aug 31, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.004
Upside: -
Micro-X Limited
Aug 31, 2026
Downgraded: Hold
Price Target: $0.08 → $0.06
Current: $0.03
Upside: +100.00%
PolyNovo Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $1.48 → $1.21
Current: $0.89
Upside: +36.72%
Aug 21, 2026
Reiterated: Buy
Price Target: $8.59
Current: $6.25
Upside: +37.44%
Jan 8, 2024
Reiterated: Hold
Price Target: $0.85 → $0.05
Current: $0.05
Upside: n/a
Aug 23, 2023
Reiterated: Buy
Price Target: $5.43 → $5.32
Current: $2.85
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $1.55
Current: $0.26
Upside: n/a
Feb 18, 2022
Reiterated: Buy
Price Target: $1.09 → $1.20
Current: $0.75
Upside: n/a
Dec 14, 2021
Downgraded: Hold
Price Target: $2.33 → $1.89
Current: $5.05
Upside: n/a